Estimating problem drinking among community pharmacy customers: What did pharmacists think of the method?

International Journal of Pharmacy Practice

Volumn 18, Issue 5, 2010, Pages 290-296

  Sheridan, Janie ^a   Smart, Ros ^a   McCormick, Ross ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

community pharmacy; methodology; prevalence; risky drinking

Indexed keywords

ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; HUMAN; INFORMATION PROCESSING; PARTICIPANT OBSERVATION; PHARMACIST; PHARMACY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEMI STRUCTURED INTERVIEW; PROCEDURES;

ALCOHOLISM; COMMUNITY PHARMACY SERVICES; DATA COLLECTION; HUMANS; PHARMACISTS; PREVALENCE;

EID: 77956401280     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.2010.00044.x     Document Type: Article

References (32)

1. Anderson C, Blenkinsopp A. Community pharmacy's contribution to improving public health: learning from local initiatives. Pharm J 2003 271 : 623 625.
2. Anderson S. The changing role of the community pharmacist in health promotion in Great Britain 1930 to 1995. Pharm Hist (Lond) 2002 32 : 7 10.
3. Bogden PE et al. The physician and pharmacist team. An effective approach to cholesterol reduction. J Gen Intern Med 1997 12 : 158 164.
4. Ibrahim OM et al. Outcome of cholesterol screening in a community pharmacy. DICP 1990 24 : 817 821.
5. Jungnickel PW, Wisehart DA. Evaluation of community pharmacists' experiences with cholesterol screening programs. J Am Pharm Assoc 1997 NS37 : 640 646.
6. Maguire TA. Cholesterol screening in the pharmacy. Pharm J 1989 242 : 574 577.
7. Mahtabjafari M et al. The value of pharmacist involvement in a point-of-care service, walk-in lipid screening program. Pharmacotherapy 2001 21 : 1403 1406.
8. Clifford RM et al. A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. Int J Pharm Pract 2002 10 : 85 89.
9. Blenkinsopp A, Hassey A. Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: a critical review of intervention design, pharmacist and patient perspectives. Int J Pharm Pract 2005 13 : 231 240.
10. Kras I. Pharmacy Diabetes Care Program. Final report to: Pharmacy Guild of Australia. Sydney: University of Sydney 2005.
11. Cerulli J, Zeolla MM. Impact and feasibility of a community pharmacy bone mineral density screening and education program. J Am Pharm Assoc 2004 44 : 161 167.
12. Elliott ME et al. Osteoporosis screening by community pharmacists: use of National Osteoporosis Foundation resources. J Am Pharm Assoc 2002 42 : 101 110. quiz 10-1.
13. Goode JV et al. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: osteoporosis. J Am Pharm Assoc (Wash DC) 2004 44 : 152 160.
14. Law AV, Shapiro K. Impact of a community pharmacist-directed clinic in improving screening and awareness of osteoporosis. J Eval Clin Pract 2005 11 : 247 255.
15. MacLaughlin EJ et al. Osteoporosis screening and education in community pharmacies using a team approach. Pharmacotherapy 2005 25 : 379 386.
16. Ciardulli LM, Goode JV. Using health observances to promote wellness in community pharmacies. J Am Pharm Assoc 2003 43 : 61 68.
17. Flobbe K et al. The pharmacy screening project - an evaluation of pharmacy-based screening programmes. S Afr Med J 1999 89 : 980 986.
18. Taylor KL et al. Acceptance of a Chlamydia screening program in community pharmacies. J Pharm Pract Res 2007 37 : 287 291.
19. Glanz A et al. Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales. Br Med J 1989 299 : 1076 1079.
20. Sheridan J et al. Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. Br Med J 1996 313 : 272 274.
21. Lawrie T et al. Pharmacy customers' views and experiences of using pharmacies which provide needle exchange services in Aberdeen and Glasgow, Scotland. Int J Drug Policy 2003 14 : 445 447.
22. Sheridan J et al. Screening and brief interventions for alcohol: attitudes, knowledge and experience of community pharmacists in Auckland, New Zealand. Drug Alcohol Rev 2008 27 : 380 387.
23. Fitzgerald N et al. Development implementation and evaluation, of a pilot project to deliver interventions on alcohol issues in community pharmacies. Int J Pharm Pract 2008 16 : 17 22.
24. Ellerby D et al. The level of interest in pharmacy practice research among community pharmacists. Pharm J 1993 251 : 321 322.
25. Liddell H. Attitudes of community pharmacists regarding involvement in practice research. Pharm J 1996 256 : 905 907.
26. Rosenbloom K et al. Community pharmacists' attitudes towards research. Int J Pharm Pract 2000 8 : 103 110.
27. Saini B et al. Factors influencing Australian community pharmacists' willingness to participate in research projects - an exploratory study. Int J Pharm Pract 2006 14 : 179 188.
28. Helgeson J et al. Determinants of mail-survey response: survey design factors and respondent factors. Psychol Mark 2002 19 : 303 328.
29. News. Safer Drinking Survey. Pharmacy Today 2008 April:3.
30. ALAC. DrinkCheck - is Your Drinking OK? Wellington: Alcohol Advisory Council of New Zealand 2007. http://www.alac.org.nz/DBTextworks/PDF/ Drinkcheck2007.pdf. (accessed 29 June 2010).
31. Alcohol Concern. Primary Care Information Service Factsheet: Screening Tools for Healthcare Settings. London: Alcohol Concern 2009. http://www.docstoc.com/docs/23115556/PRIMARY-CARE-ALCOHOL-INFORMATION-SERVICE- Factsheet (accessed 29 June 2010).
32. Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res 2007 31 : 185 199.